PERSPECTA

News from every angle

Back to headlines

Oxytetracyclin Eye Ointment Recalled from Market Due to Incorrect Active Substance

A specific batch of Oxytetracyclin eye ointment is being recalled from the market after a wrong active substance was discovered in one package within the EU.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.